Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (272 million pounds) over five years over Washington's demand for sensitive information.
This move was revealed following a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesperson later explained that the US was demanding access to biological samples for research and commercial purposes while was not willing to share the benefits from future vaccines.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more dialogue to secure a deal agreeable to all parties so the country's critical HIV programme can continue.
Wider Context
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a high court blocked a similar deal with the US after concerns were filed about the security of citizens' health data.
After returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and accountability.
Based on reports, Sixteen African countries have so far agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," he stated.
"In essence, our country would provide the raw materials for medical research with no certainty that the final treatments would be accessible to our people if a future health crisis arise."
National Interest and International Frameworks
Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were disrupting systems already set up via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This framework is designed to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but recommended that negotiations should continue considering a large portion of the country's HIV programmes were funded by external financing.
"If specific concerns arise, such as those relating to data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it added.
This impasse underscores the ongoing challenges between receiving crucial foreign assistance and protecting a country's data in an increasingly interconnected world.